The Role of the Health Care Provider in Improving Quality of Life for Patients with Overactive Bladder

Archived Sessions:

This is an internet-based activity that should take 1 hour to complete.

To participate in this archived webinar learners should:

• Take the pretest
• Listen to webinar
• Take the post-test
• Complete follow-up evaluation survey

Learning Objectives

At the conclusion of this program, participants should be able to:

• Demonstrate effective counseling skills in order to facilitate conversations about OAB with appropriate patients
• Recognize the signs of OAB and conduct a differential diagnosis with appropriate patients in order to provide evidence-based care
• Provide pharmacological and non-pharmacological treatments, emphasizing adherence, to address OAB in appropriate patients
• Develop strategies for the provision of patient centered care, including the provision of an appropriate referral to a specialist

Accreditation Information

Physicians:

ACCREDITATION
The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION
ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses:

This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour, including up to 0.5 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.

Others:

A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 Credit^TM. 

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through educational grants from Allergan, Inc., Astellas Pharma Inc., and Pfizer Inc.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Advisory Committee Disclosures

ARHP Staff/Consultant Disclosures